Episode 35: From NASA to Naked Mole Rats: The Science Behind ValAsta

A terminal cancer diagnosis pushed physicist Samuel Shepard to find the one molecule that keeps five different species from ever getting cancer. In this episode of Common-Sense Wellness, Dr. Gary Martin discusses inflammation science with physicist, inventor, and cancer survivor Samuel Shepard. Facing an untreatable bone marrow cancer diagnosis in 2003, Samuel turned his engineering background toward a search for cancer-resistant species and discovered astaxanthin. He explains how attaching a glucose molecule to astaxanthin, the innovation behind his patented ValAsta, makes it up to eight times more bioavailable than standard supplements. The conversation dives into how free radical damage to DNA drives roughly 92 percent of chronic disease, and why targeting inflammation at its root matters more than treating symptoms. Key Takeaways: → Only five species on Earth appear to resist cancer entirely — salmon, pink flamingos, sharks, elephants, and naked mole rats — and Samuel's research traced their common thread to astaxanthin. → Attaching a glucose molecule to astaxanthin lets it hitch a ride through the body's glucose channels, making Samuel's ValAsta formula up to eight times more bioavailable than typical astaxanthin supplements. → Free radical damage to the guanine base in DNA produces the same underlying mutation found in every cancer, just in different organs. → Cancer cells consume 16 times more glucose than healthy cells, a vulnerability that Samuel's delivery system uses to carry astaxanthin directly where it's needed. → As glutathione production drops by up to 80 percent with age, the body's ability to clear free radicals declines, setting the stage for the chronic inflammation behind arthritis, diabetes, and Alzheimer's. Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery. In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets. Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience. Connect With Samuel Shepard: Website: https://valasta.net/ YouTube: https://www.youtube.com/@ValAsta